D-1147-2014 Class II Terminated
FDA drug recall D-1147-2014 was initiated by Hospira Inc. on Feb 10, 2014 and is designated Class II. Reason for recall: Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial. The recall status is terminated (terminated Feb 1, 2017). Affected quantity: 115,500 Vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Mar 12, 2014
- Initiation Date
- Feb 10, 2014
- Termination Date
- Feb 1, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 115,500 Vials
Product Description
Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1162-02
Reason for Recall
Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial.
Distribution Pattern
Nationwide
Code Information
Lot 25-097-DK; Exp 01/01/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1147-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026